INNOVATE Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Paul Voigt

Algemeen directeur

US$481.5k

Totale compensatie

Percentage CEO-salaris	43.5%
Dienstverband CEO	1.6yrs
Eigendom CEO	2.6%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	3.7yrs

Recente managementupdates

Recent updates

INNOVATE Corp.'s (NYSE:VATE) Shares Bounce 81% But Its Business Still Trails The Industry

Jan 22

INNOVATE Corp. (NYSE:VATE) Held Back By Insufficient Growth Even After Shares Climb 81%

Jan 22

These 4 Measures Indicate That HC2 Holdings (NYSE:HCHC) Is Using Debt Extensively

Apr 13

HC2 Holdings Simplification Process Could Lead To Rerate

Feb 01

HC2 to sell clean energy business for $169M

Dec 31

HC2's insurance segment to be acquired by Continued General

Dec 10

The Independent Chairman of the Board of HC2 Holdings, Inc. (NYSE:HCHC), Avram Glazer, Just Bought 16% More Shares

Dec 10

HC2 owner acquires additional shares

Dec 09

HC2 Holdings +12.6% as Chairman Glazer buys $9M in stock

Dec 03

HC2 Holdings appoints CEO

Nov 30

Have Insiders Sold HC2 Holdings, Inc. (NYSE:HCHC) Shares Recently?

Nov 26

Analyse CEO-vergoeding

Hoe is Paul Voigt's beloning veranderd ten opzichte van INNOVATE's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$31m
Jun 30 2024	n/a	n/a	-US$23m
Mar 31 2024	n/a	n/a	-US$40m
Dec 31 2023	US$481k	US$210k	-US$38m
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	-US$34m
Mar 31 2023	n/a	n/a	-US$37m
Dec 31 2022	n/a	n/a	-US$41m
Sep 30 2022	n/a	n/a	-US$39m
Jun 30 2022	n/a	n/a	-US$45m
Mar 31 2022	n/a	n/a	-US$53m
Dec 31 2021	n/a	n/a	-US$80m
Sep 30 2021	n/a	n/a	-US$88m
Jun 30 2021	n/a	n/a	-US$101m
Mar 31 2021	n/a	n/a	-US$74m
Dec 31 2020	n/a	n/a	-US$46m
Sep 30 2020	n/a	n/a	-US$64m
Jun 30 2020	n/a	n/a	-US$46m
Mar 31 2020	n/a	n/a	-US$35m
Dec 31 2019	n/a	n/a	-US$18m
Sep 30 2019	n/a	n/a	-US$1m
Jun 30 2019	n/a	n/a	US$143m
Mar 31 2019	n/a	n/a	US$176m
Dec 31 2018	US$2m	US$114k	US$139m

Compensatie versus markt: De totale vergoeding ($USD 481.49K ) Paul } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.38M ).

Compensatie versus inkomsten: De vergoeding van Paul is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Paul Voigt (65 yo)

1.6yrs

Tenure

US$481,486

Compensatie

Mr. Paul Kenneth Voigt served as Senior Managing Director of Investments at HC2 Holdings, Inc. from October 2014 to May 9, 2018. He is Interim Chief Executive Officer at INNOVATE Corp. since July 26, 2023....

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Avram Glazer	Independent Chairman of the Board	4.8yrs	US$175.13k	50.99% $ 82.9m
Warren Gfeller	Independent Director	8.7yrs	US$168.38k	0.39% $ 629.4k
Brian Goldstein	Independent Director	2.7yrs	US$251.75k	0.25% $ 399.9k
Amy Wilkinson	Independent Director	2.5yrs	US$157.88k	0.23% $ 374.4k

3.7yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van VATE wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/02/06 13:48
Aandelenkoers aan het einde van de dag	2025/02/06 00:00
Inkomsten	2024/09/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

INNOVATE Corp. wordt gevolgd door 2 analisten. 0 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Sarkis Sherbetchyan	B. Riley Securities, Inc.
Barry Sine	Drexel Hamilton

INNOVATE Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Interim Chief Executive Officer recently bought US$100k worth of stock

Interim Chief Executive Officer recently bought US$166k worth of stock

Independent Chairman of the Board exercised options to buy US$27m worth of stock.

INNOVATE Corp., Annual General Meeting, Jun 13, 2024

INNOVATE Corp. to Cease Suzi Herbst as Chief Operating Officer on or Around October 20, 2023

Innovate Corp. Announces Chief Executive Officer Changes

Recent updates

INNOVATE Corp. Announces U.S. Food and Drug Administration Approved the MediBeacon TGFR for the Assessment of Kidney Function in Patients with Normal or Impaired Renal Function

INNOVATE Corp.'s (NYSE:VATE) Shares Bounce 81% But Its Business Still Trails The Industry

INNOVATE Corp. (NYSE:VATE) Held Back By Insufficient Growth Even After Shares Climb 81%

New major risk - Share price stability

Interim Chief Executive Officer recently bought US$100k worth of stock

Third quarter 2024 earnings released: US$1.18 loss per share (vs US$0.93 loss in 3Q 2023)

INNOVATE Corp. to Report Q3, 2024 Results on Nov 06, 2024

Interim Chief Executive Officer recently bought US$166k worth of stock

INNOVATE Regains Compliance with NYSE Minimum Price Requirement

Second quarter 2024 earnings released: EPS: US$0.16 (vs US$0.14 loss in 2Q 2023)

INNOVATE Corp. to Report Q2, 2024 Results on Aug 07, 2024

New major risk - Shareholder dilution

Independent Chairman of the Board exercised options to buy US$27m worth of stock.

New major risk - Share price stability

First quarter 2024 earnings released: US$0.23 loss per share (vs US$0.13 loss in 1Q 2023)

INNOVATE Corp., Annual General Meeting, Jun 13, 2024

Now 30% overvalued

INNOVATE Corp. to Report Q1, 2024 Results on May 07, 2024

Now 20% overvalued

Now 21% undervalued after recent price drop

Full year 2023 earnings released: US$0.45 loss per share (vs US$0.53 loss in FY 2022)

INNOVATE Corp. has filed a Follow-on Equity Offering in the amount of $19 million.

INNOVATE Receives Written Notice from the New York Stock Exchange Regarding Non-Compliance with the Continued Listing Standard Set in Section 802.01C of the NYSE’s Listed Company Manual

INNOVATE Corp. has filed a Follow-on Equity Offering.

INNOVATE Corp. to Report Q4, 2023 Results on Mar 04, 2024

Third quarter 2023 earnings released: US$0.093 loss per share (vs US$0.085 loss in 3Q 2022)

INNOVATE Corp. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Market cap size

INNOVATE Corp. to Cease Suzi Herbst as Chief Operating Officer on or Around October 20, 2023

Second quarter 2023 earnings released: US$0.14 loss per share (vs US$0.17 loss in 2Q 2022)

Innovate Corp. Announces Chief Executive Officer Changes

INNOVATE Corp. Announces the Demise of Wayne Barr, President and Director

INNOVATE Corp. to Report Q2, 2023 Results on Aug 08, 2023

Innovate: Infrastructure Growth And Glacial AI Could Imply Undervaluation

New major risk - Share price stability

First quarter 2023 earnings released: US$0.13 loss per share (vs US$0.18 loss in 1Q 2022)

Full year 2022 earnings released: US$0.53 loss per share (vs US$1.04 loss in FY 2021)

INNOVATE Corp. to Report Q4, 2022 Results on Mar 08, 2023

Best New Idea For 2023: Innovate

Third quarter 2022 earnings released: US$0.085 loss per share (vs US$0.17 loss in 3Q 2021)

INNOVATE Receives Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard from NYSE

Innovate GAAP EPS of -$0.09, revenue of $423M

INNOVATE Corp. to Report Q3, 2022 Results on Nov 02, 2022

INNOVATE Corp. Announces Resignation of Joseph Ferraro as Chief Legal Officer

Second quarter 2022 earnings released: US$0.16 loss per share (vs US$0.29 loss in 2Q 2021)

Innovate GAAP EPS of -$0.18, revenue of $392.2M

INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

INNOVATE Corp. to Report Q2, 2022 Results on Aug 03, 2022

INNOVATE Notifies NYSE That the Company Was No Longer in Compliance with Section 303A.07(a) of the NYSE Listed Company Manual

INNOVATE Corp.(NYSE:VATE) dropped from Russell 2000 Dynamic Index

Independent Director recently sold US$67k worth of stock

INNOVATE Corp. Announces Board of Directors Resignations

Independent Chairman of the Board recently bought US$1.1m worth of stock

First quarter 2022 earnings: EPS and revenues miss analyst expectations

INNOVATE Corp. to Report Q1, 2022 Results on May 04, 2022

INNOVATE Corp. to Report Q1, 2022 Results on May 04, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

INNOVATE Corp. to Report Q4, 2021 Results on Mar 09, 2022

INNOVATE Corp. Promotes Suzi Raftery Herbst to Chief Operating Officer of the Company

Third quarter 2021 earnings released: US$0.17 loss per share (vs US$0.38 loss in 3Q 2020)

Breaking Down Innovate's Potential

Second quarter 2021 earnings released: US$0.29 loss per share (vs US$0.098 profit in 2Q 2020)

HC2 Holdings, Inc.(NYSE:HCHC) dropped from Russell Microcap Growth Index

HC2 Holdings: A Granular Assessment

First quarter 2021 earnings released: US$0.51 loss per share (vs US$0.51 loss in 1Q 2020)

HC2 Holdings reports Q1 results

These 4 Measures Indicate That HC2 Holdings (NYSE:HCHC) Is Using Debt Extensively

Chief Financial Officer recently sold US$59k worth of stock

HC2 Holdings, Inc. to Report Q4, 2020 Results on Mar 10, 2021